a Department of Pharmaceutical Organic Chemistry , Beni-Suef University , Beni-Suef , Egypt.
b Biochemistry Department, Cairo General Hospital , Cairo , Egypt , and.
J Enzyme Inhib Med Chem. 2016;31(sup3):54-60. doi: 10.1080/14756366.2016.1201815. Epub 2016 Aug 10.
A new series of 1,5-diarylpyrazoles 10a-l was designed and synthesized for evaluation as COX inhibitors and as anti-inflammatory agents. All compounds were more selective for COX-2 isozyme and showed good in vivo anti-inflammatory activity. Compound 10e was the most COX-2 selective compound (S.I. = 10.67) and the most potent anti-inflammatory derivative (ED = 46 μmol/kg) which is approximately 11-folds more potent than ibuprofen (ED = 499 μmol/kg) and had 2/3 potency of celecoxib (ED = 31 μmol/kg). All compounds were less ulcerogenic (ulcer indexes = 1.20-4.61) than ibuprofen (ulcer index = 20.25) and comparable to celecoxib (ulcer index = 2.90).
为了评估其作为 COX 抑制剂和抗炎药的效果,我们设计并合成了一系列新的 1,5-二芳基吡唑 10a-l。所有化合物对 COX-2 同工酶的选择性更高,并且具有良好的体内抗炎活性。化合物 10e 是最具 COX-2 选择性的化合物(S.I. = 10.67),也是最有效的抗炎衍生物(ED = 46 μmol/kg),其效力约为布洛芬(ED = 499 μmol/kg)的 11 倍,与塞来昔布(ED = 31 μmol/kg)的效力相当。所有化合物的致溃疡指数(ulcer indexes)均低于布洛芬(ulcer index = 20.25),与塞来昔布(ulcer index = 2.90)相当。